Last update :
03/05/2024
References   References 3129  
Type : Manufacturer

Research teams :
Authors :
Title : Irinotécan (Campto®) – Résumé des caractéristiques du produits
Reference : Pfizer 2008

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionIrinotecan Anticancer drug
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% mg/ml 30°C Protect from light
28 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% mg/ml 30°C
3 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% mg/ml 5°C Not specified
28 Day
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% mg/ml 30°C Protect from light
28 Day
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% mg/ml 30°C
3 Day
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% mg/ml 5°C Not specified
28 Day

  Mentions Légales